Garden State Investment Advisory Services’s Merck MRK Stock Holding History

Garden State Investment Advisory Services’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,264	Closed	-$276K	–	341
2025 Q3	$276K	Sell	3,264 -115	-3%	-$9.47K	0.06%	241
2025 Q2	$270K	Sell	3,379 -328	-9%	-$26.1K	0.07%	235
2025 Q1	$334K	Buy	+3,707	New	+$346K	0.11%	174

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Garden State Investment Advisory Services's MRK Position: Q4 2025 in Review

Garden State Investment Advisory Services sold out of Merck (MRK) in Q4 2025, closing a stake of 3,264 shares — an estimated $276K sold.

Garden State Investment Advisory Services first reported a position in MRK in Q1 2025 and held it in 3 quarters. The position peaked at $334K in Q1 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Garden State Investment Advisory Services reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Garden State Investment Advisory Services sold 3,264 Merck shares in Q4 2025, an estimated $276K.
Garden State Investment Advisory Services first reported a position in Merck in Q1 2025 and held it in 3 quarters.
Garden State Investment Advisory Services's Merck position peaked at $334K in Q1 2025.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Garden State Investment Advisory Services's 13F filing for Q4 2025, filed 17 Feb 2026.